Pelthos Therapeutics Inc. SEC filings PTHS
Pelthos Therapeutics Inc. has 253 filings in SEC EDGAR's recent list, going back to Sep 6, 2022. Its latest annual report, Form ARS, was filed on Aug 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (material agreement, new debt, unregistered share sale, change to shareholder rights, officer or director change, bylaw or fiscal year change, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 3, 2026 | — |
| 4 | Insider transaction | Oct 6, 2026 | Oct 2, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 2, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 2, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 2, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 2, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 2, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 144 | Notice of proposed sale | May 22, 2026 | — |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 7, 2026 | — |
| 3 | Initial insider ownership | Apr 20, 2026 | Apr 10, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4/A | Form 4/a | Apr 1, 2026 | Jun 14, 2024 |
| 4/A | Form 4/a | Apr 1, 2026 | Jun 14, 2024 |
| 4/A | Form 4/a | Apr 1, 2026 | Jun 14, 2024 |
| 4/A | Form 4/a | Apr 1, 2026 | Jul 2, 2025 |
| 4/A | Form 4/a | Apr 1, 2026 | Jul 2, 2025 |
| 4/A | Form 4/a | Apr 1, 2026 | Jul 2, 2025 |
| 4/A | Form 4/a | Apr 1, 2026 | Jul 2, 2025 |
| 4/A | Form 4/a | Apr 1, 2026 | Jul 2, 2025 |
| 4/A | Form 4/a | Apr 1, 2026 | Jul 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 4 | Insider transaction | Dec 29, 2025 | Dec 23, 2025 |
| 3 | Initial insider ownership | Dec 29, 2025 | Dec 23, 2025 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 10, 2025 | Nov 6, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 4 | Insider transaction | Jul 23, 2025 | Jul 2, 2025 |
| 3 | Initial insider ownership | Jul 23, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 21, 2025 | Jul 2, 2025 |
| 3 | Initial insider ownership | Jul 21, 2025 | Jul 2, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 8, 2025 | — |
| 4 | Insider transaction | Jul 7, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jul 2, 2025 |
| 3 | Initial insider ownership | Jul 7, 2025 | Jul 1, 2025 |
| 3 | Initial insider ownership | Jul 7, 2025 | Jul 1, 2025 |
| 3 | Initial insider ownership | Jul 7, 2025 | Jul 1, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 3, 2025 | — |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Jul 3, 2025 | — |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 3 | Initial insider ownership | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Apr 15, 2025 | Apr 11, 2025 |
| 4 | Insider transaction | Apr 15, 2025 | Apr 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 15, 2025 | — |
| 4 | Insider transaction | Nov 15, 2024 | Nov 13, 2024 |
| 4 | Insider transaction | Nov 15, 2024 | Nov 13, 2024 |
| 4 | Insider transaction | Nov 15, 2024 | Nov 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 10, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 3/A | Filing | Jul 2, 2024 | Feb 15, 2024 |
| 4/A | Filing | Jun 18, 2024 | Feb 21, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4/A | Filing | Mar 12, 2024 | Feb 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 4, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 1, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 1, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 1, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 1, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 1, 2024 | — |
| SC 13D | Ownership over 5% (active) | Feb 26, 2024 | — |
| 4 | Insider transaction | Feb 23, 2024 | Feb 21, 2024 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 21, 2024 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 21, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Feb 15, 2024 |
Showing 103 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PTHS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Durham, NC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1919246
- Former names
- Channel Therapeutics Corp (until May 27, 2025); Chromocell Therapeutics Corp (until Nov 15, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.